Jennifer Chickering

Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease

John P. Hanrahan, Ian H. de Boer, George L. Bakris et al. · Clinical Journal of the American Society of Nephrology · 2020 · 36 citations · Full text

An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension

John P. Hanrahan, Jelena Seferović, James Wakefield et al. · Diabetologia · 2019 · 33 citations · Full text

Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease

Daniel P. Zimmer, Courtney Shea, Jenny Tobin et al. · Frontiers in Pharmacology · 2020 · 33 citations · Full text

A Randomized, Placebo‐Controlled, Multiple‐Ascending‐Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Soluble Guanylate Cyclase Stimulator Praliciguat in Healthy Subjects

John P. Hanrahan, James Wakefield, Phebe Wilson et al. · Clinical Pharmacology in Drug Development · 2018 · 27 citations · Full text